Drug controller general of India

DCGI Grants Approval for Pneumococcal Polysaccharide Conjugate Vaccine to Serum Institute

This vaccine has been developed by M/s. Serum Institute of India Pvt. Ltd, Pune. Serum Institute first obtained the approval of DCGI to conduct Phase I, Phase II and Phase III clinical trials of Pneumococcal Polysaccharide Conjugate Vaccine in India.